Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
Bioventus Inc. (Nasdaq: BVS), a global leader in active healing innovations, has announced its plans to release second quarter fiscal year 2024 financial results on August 6, 2024, before the market opens. The company will host a conference call at 8:30 a.m. Eastern Time on the same day to discuss the results and provide a business update.
Interested parties can participate in the conference call by dialing 1-833-636-0497 and referring to the Bioventus Inc. Conference Call. Additionally, a live webcast of the call and accompanying materials will be available on the company's Investor Relations website. The webcast will be archived and accessible for replay until August 5, 2025.
Bioventus Inc. (Nasdaq: BVS), un leader globale nelle innovazioni per la guarigione attiva, ha annunciato i suoi piani per rilasciare i risultati finanziari del secondo quarto dell'anno fiscale 2024 il 6 agosto 2024, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica alle 8:30 a.m. Eastern Time lo stesso giorno per discutere i risultati e fornire un aggiornamento aziendale.
Le parti interessate possono partecipare alla conferenza telefonica componendo il numero 1-833-636-0497 e facendo riferimento alla Conferenza Telefonica di Bioventus Inc. Inoltre, sarà disponibile un webcast dal vivo della chiamata e i materiali associati sul sito web delle Relazioni con gli Investitori dell'azienda. Il webcast sarà archiviato e accessibile per il replay fino al 5 agosto 2025.
Bioventus Inc. (Nasdaq: BVS), un líder global en innovaciones para la sanación activa, ha anunciado sus planes para publicar los resultados financieros del segundo trimestre del año fiscal 2024 el 6 de agosto de 2024, antes de la apertura del mercado. La empresa organizará una llamada de conferencia a las 8:30 a.m. Hora del Este el mismo día para discutir los resultados y proporcionar una actualización del negocio.
Las partes interesadas pueden participar en la llamada de conferencia marcando el 1-833-636-0497 y refiriéndose a la Llamada de Conferencia de Bioventus Inc. Además, habrá un webcast en vivo de la llamada y materiales acompañantes disponibles en el sitio web de Relaciones con Inversores de la empresa. El webcast se archivará y será accesible para repetición hasta el 5 de agosto de 2025.
Bioventus Inc. (Nasdaq: BVS)는 글로벌 활성 치유 혁신 리더로서 2024 회계연도 2분기 재무 결과를 2024년 8월 6일에 시장 개장 전에 발표할 계획이라고 발표했습니다. 회사는 같은 날 동부 표준시 기준 오전 8시 30분에 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 컨퍼런스 콜을 개최할 예정입니다.
관심 있는 당사자는 1-833-636-0497로 전화하여 Bioventus Inc. 컨퍼런스 콜에 언급함으로써 참여할 수 있습니다. 또한, 회사의 투자자 관계 웹사이트에서 통화의 라이브 웹캐스트와 관련 자료를 확인할 수 있습니다. 웹캐스트는 아카이브되어 2025년 8월 5일까지 다시 볼 수 있습니다.
Bioventus Inc. (Nasdaq: BVS), un leader mondial dans les innovations de guérison active, a annoncé ses projets de publier les résultats financiers du deuxième trimestre de l'exercice fiscal 2024 le 6 août 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 8h30, heure de l'Est le même jour pour discuter des résultats et fournir une mise à jour sur les affaires.
Les parties intéressées peuvent participer à la conférence téléphonique en composant le 1-833-636-0497 et en faisant référence à la conférence téléphonique de Bioventus Inc. De plus, un webinaire en direct de l'appel et des documents d'accompagnement seront disponibles sur le site Web des relations avec les investisseurs de l'entreprise. Le webinaire sera archivé et accessible en replay jusqu'au 5 août 2025.
Bioventus Inc. (Nasdaq: BVS), ein weltweit führendes Unternehmen für aktive Heilinnovationen, hat angekündigt, die Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2024 am 6. August 2024, vor Markteröffnung, zu veröffentlichen. Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Telefonkonferenz durchführen, um die Ergebnisse zu besprechen und ein Update zum Geschäft zu geben.
Interessierte Parteien können an der Telefonkonferenz teilnehmen, indem sie 1-833-636-0497 wählen und sich auf die Bioventus Inc. Telefonkonferenz beziehen. Darüber hinaus wird eine Live-Übertragung der Konferenz sowie Begleitmaterialien auf der Investor-Relations-Website des Unternehmens verfügbar sein. Die Übertragung wird archiviert und bis zum 5. August 2025 für eine Wiederholung zugänglich sein.
- None.
- None.
DURHAM, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2024 before the market opens on Tuesday, August 6, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until August 5, 2025.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
FAQ
When will Bioventus (BVS) report its Q2 2024 financial results?
How can I participate in Bioventus' (BVS) Q2 2024 earnings call?
Where can I find the webcast for Bioventus' (BVS) Q2 2024 earnings call?
How long will Bioventus' (BVS) Q2 2024 earnings call webcast be available for replay?
